Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post on X:
” ‘We’re in this weird space where it’s technically available and costs aren’t passed onto patients…but if NCCN was going to recommend it, what would that cost the healthcare system and is it worth it?’
Kristen Ciombor opines on NCCN recs and discusses the pros/cons of ctDNA testing with her patients.”
Proceed to the video attached to the post.
More posts featuring Nina Niu Sanford.